Pillstats
Rx only · Tablet · Oral

Losartan Potassium

Losartan Potassium

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US32 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)52175
US makers7 labelers
Packages72
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.010$0.020$0.029$0.039Dec 2025May 2026Jul 2026
$0.033
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
7
Active US suppliers
49%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

19K37K56K74K2025 Q12025 Q22025 Q32025 Q42026 Q1
55K
Rx · 2026 Q1
2.8M
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager23SUPPLYING
Jubilant Cadista Pharmaceuticals Inc.unknown12SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown12SUPPLYING
AiPing Pharmaceutical, Inc.unknown9SUPPLYING
A-S Medication Solutionsunknown9SUPPLYING
Lupin Pharmaceuticals,Inc.unknown6SUPPLYING
Coupler LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 31, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03), b) 1000-count bottles (NDC# 68180-376-…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide

  • Mar 31, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC# 68180-377-…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide

  • Mar 31, 2022
    RECALLRecall (Class II): Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-37…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide